Long-term Investments (Tables)

12 Months Ended

Dec. 31, 2022

Investments, Debt and Equity Securities [Abstract]

Schedule Of Long-term investments - debt securities

The Company determined the warrants to have a nominal value at inception due to lack of marketability and as of December 31, 2022 due to its bankruptcy.

The Symbiont debt security consisted of the following:

	December 31, 2022			December 31, 2021
Symbiont.IO note receivable	$	2,027,178		$	2,000,000
Accrued interest income on debt securities		320,000			27,178
Accrued recovery of legal fees		55,364			-
Allowance for losses on debt security		(1,052,542	)		-
End of period	$	1,350,000		$	2,027,178

Schedule of Long-term Investment - equity securities

Long-term investments - equity securities" consist of the following:

Seastar Medical (formerly LMAO) Warrants	December 31, 2022			December 31, 2021
Seastar Medical (formerly LMAO) warrants	$	464,778		$	1,973,413
End of period	$	464,778		$	1,973,413
	December 31, 2022			December 31, 2021
Beginning of year	$	1,973,413		$	-
Investments in equity securities		-			5,738,000
Unrealized gain (loss) on equity securities		(1,508,635	)		(3,764,587	)
End of period	$	464,778		$	1,973,413

Summary of Investment in Unconsolidated Affiliates

	December 31, 2022		December 31, 2021
Seastar Medical Holding Corporation common stock	$	10,608,750	$	-
Investment in unconsolidated affiliate		-		4,676,130
End of period	$	10,608,750	$	4,676,130
	December 31, 2022		December 31, 2021
Beginning of year	$	4,676,130	$	25,000
Unrealized gain on equity investment		5,932,620		4,651,130
End of period	$	10,608,750	$	4,676,130